drugset / Trial / NCT05011760

[C-11]NPA PET-amphetamine in Cocaine Use Disorders

NCT05011760

NaSingle-groupOpen-labelBasic science

Summary

This study uses \[11C\]NPA positron emission tomography (PET) and a d-amphetamine challenge to image amphetamine induced dopamine release in the striatum in subjects with cocaine use disorders (CUD). Amphetamine-induced dopamine release data from this study will be correlated with \[11C\]NOP-1A VT measured at baseline in the midbrain. \[11C\]NOP-1A PET data will be used from aim 1 (see, Study Record: Imaging CRF X NOP interactions in Cocaine Use Disorders)

Timeline

Start
2021-01-31
Primary completion
2028-09-01
Completion
2028-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextroamphetamine Small molecule 0.5 mg/kg Oral